CervoMed Statistics

Total Valuation

CervoMed has a market cap or net worth of $79.57 million. The enterprise value is $32.91 million.

Market Cap	79.57M
Enterprise Value	32.91M

Important Dates

The last earnings date was Tuesday, November 12, 2024, before market open.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

CervoMed has 8.25 million shares outstanding. The number of shares has increased by 510.12% in one year.

Current Share Class	8.25M
Shares Outstanding	8.25M
Shares Change (YoY)	+510.12%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	35.20%
Owned by Institutions (%)	27.28%
Float	4.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.15
Forward PS	39.00
PB Ratio	1.74
P/TBV Ratio	1.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.27
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.04

Current Ratio	15.04
Quick Ratio	14.45
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -43.28% and return on invested capital (ROIC) is -28.68%.

Return on Equity (ROE)	-43.28%
Return on Assets (ROA)	-25.99%
Return on Capital (ROIC)	-28.68%
Revenue Per Employee	$1.26M
Profits Per Employee	-$1.49M
Employee Count	8
Asset Turnover	0.33
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.33% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-2.33%
50-Day Moving Average	13.58
200-Day Moving Average	17.16
Relative Strength Index (RSI)	27.76
Average Volume (20 Days)	78,774

Short Selling Information

The latest short interest is 1.48 million, so 17.96% of the outstanding shares have been sold short.

Short Interest	1.48M
Short Previous Month	1.27M
Short % of Shares Out	17.96%
Short % of Float	36.31%
Short Ratio (days to cover)	18.85

Income Statement

In the last 12 months, CervoMed had revenue of $10.07 million and -$11.95 million in losses. Loss per share was -$1.60.

Revenue	10.07M
Gross Profit	-4.50M
Operating Income	-12.67M
Pretax Income	-5.04M
Net Income	-11.95M
EBITDA	n/a
EBIT	-12.67M
Loss Per Share	-$1.60

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	46.66M
Total Debt	n/a
Net Cash	46.66M
Net Cash Per Share	$5.65
Equity (Book Value)	45.64M
Book Value Per Share	5.53
Working Capital	45.56M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-11.02M
Capital Expenditures	n/a
Free Cash Flow	-11.02M
FCF Per Share	-$1.33

Full Cash Flow Statement

Margins

Gross margin is -44.71%, with operating and profit margins of -125.83% and -118.68%.

Gross Margin	-44.71%
Operating Margin	-125.83%
Pretax Margin	-118.68%
Profit Margin	-118.68%
EBITDA Margin	n/a
EBIT Margin	-125.83%
FCF Margin	-35.85%

Dividends & Yields

CervoMed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-510.12%
Shareholder Yield	-510.12%
Earnings Yield	-15.02%
FCF Yield	-13.85%

Analyst Forecast

The average price target for CervoMed is $53.67, which is 456.74% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$53.67
Price Target Difference	456.74%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	38.70%
EPS Growth Forecast (5Y)	70.71%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CervoMed has an Altman Z-Score of 18.28 and a Piotroski F-Score of 2.

Altman Z-Score	18.28
Piotroski F-Score	2